# GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says

> HelixNews · Web page: https://helixnews.one/story/439208 · All pages for agents: https://helixnews.one/llms.txt

7 outlets covering · First listed: CBS News, Nov 10, 2026, 7:59 PM · Read it: <https://www.cbsnews.com/video/glp-1-drugs-to-carry-warning-about-rare-vision-loss-side-effect-fda-says/>

GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News' "The Daily Report" to discuss.

## Who's covering it

In the order they published:

- Nov 10, 2026, 8:43 AM: [FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound](<https://www.cnbc.com/2026/11/10/fda-warning-vision-loss-glp1-wegovy-zepbound.html>) — CNBC (Business & finance, United States)
  The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
- Nov 10, 2026, 8:43 AM: [FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss](<https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/>) — Ars Technica (Digital news, United States)
  The risk appears small and data is mixed, but FDA wants patients to be aware.
- Nov 10, 2026, 11:10 AM: [FDA adds rare vision-loss warning to popular GLP-1 drugs](<https://news.google.com/rss/articles/CBMitAFBVV95cUxNbXh3V3c4bjdlRlQ5ZENic0ktQ1gteGtUNDNPWml6cmktT2VmcC1HMGdLTmNHT1U0V0JUYngwel90aTY5UFRYUzBKSFNnMUJVRHRTSVFLbGFmdjZiVTFtOC02T0UwTGFWX1VNY25jLXYyQXZ0WFQ5UWk4bFptSHROR1Z1Y25DU01NTC01NVNEeDd6SVBhbW96RXBqNlRKRFFZc3UwcXJzc1kwcWtxT1dzUHNiUnE?oc=5>) — AP (Wire service, United States)
- Nov 10, 2026, 12:21 PM: [The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss](<https://www.marketwatch.com/story/ozempic-zepbound-and-other-glp-1-drugs-have-a-possible-risk-of-vision-loss-b3738f36?mod=mw_rss_topstories>) — MarketWatch (Business & finance, United States)
  Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.
- Nov 10, 2026, 2:18 PM: [FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications](<https://www.theguardian.com/us-news/2026/nov/10/fda-glp-1-weight-loss-blindness-risk>) — Guardian (Newspaper, United Kingdom)
- Nov 10, 2026, 4:28 PM: [FDA warns weight loss drugs may increase risk of sudden vision loss](<https://news.google.com/rss/articles/CBMisAFBVV95cUxOX0hCZmRUQnRwUjhzbWdURmtGbks1N2N6N2k5R2RYY0VySXI3V2hkY05LV2lTLUN6ZERZcjNlX3pWdXYySmVDOS1CdEI5OE05ZXV1S05nTXJLYUtreEVJRUVQN01ZNkhXYnhpeFd4NmZCRzQ2R3hZMjdGWkNNQ1NfQ0ZBOWlQNG9rdGx3VW55U1h2cjhLMG1GX3VzZTRGd3ctZkdVRW5TWnVJYkgzZlZpYQ?oc=5>) — CNN (TV network, United States)
- Nov 10, 2026, 7:59 PM: [GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says](<https://www.cbsnews.com/video/glp-1-drugs-to-carry-warning-about-rare-vision-loss-side-effect-fda-says/>) — CBS News (TV network, United States)
  GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News' "The Daily Report" to discuss.